Results 81 to 90 of about 20,554 (221)

Hypophosphatemia and Hyperphosphatemia

Critical Care Clinics, 1991
Pathophysiology, clinical sequelae, and treatment for hypophosphatemia and hyperphosphatemia are discussed. Hypophosphatemia results from a variety of conditions including malnutrition, carbohydrate refeeding, acid-base disorders, and hormonal and drug effects. Patients suffering from severe hypophosphatemia may present with a variety of syndromes that
Michael P. Peppers, Michael Geheb, Tusar Desai   +2 more
openaire   +3 more sources

Efficacy of a Once-Daily Supplement in Managing Canine Chronic Kidney Disease

Animals
Background: Chronic kidney disease (CKD) in companion animals leads to progressive renal deterioration and metabolic complications such as hyperphosphatemia and metabolic acidosis, particularly in advanced stages.
Francesca Perondi, Alessio Ruggiero, Monica Isabella Cutrignelli, Ilaria Lippi, Giorgia Meineri, Elisa Martello   +5 more
doaj   +1 more source

The serum level of the morphogenetic protein fibroblast growth factor 23 (FGF-23) as a marker for the efficiency of hyperphosphatemia therapy with phosphate-binding agents in chronic kidney disease [PDF]

Терапевтический архив, 2016
Aim. To study whether the excessive production of serum fibroblast growth factor 23 (FGF-23) may be reduced with phosphate-binding agents to treat hyperphosphatemia in patients with Stage VD chronic kidney disease (CKD). Subjects and methods.
N A Mukhin, Yu S Milovanov, L V Kozlovskaya, I A Dobrosmyslov, L Yu Milovanova   +4 more
doaj  

Oral calcium carbonate affects calcium but not phosphorus balance in stage 3–4 chronic kidney disease [PDF]

, 2013
Chronic kidney disease (CKD) patients are given calcium carbonate to bind dietary phosphorus and reduce phosphorus retention, and to prevent negative calcium balance. Data are limited on calcium and phosphorus balance in CKD to support this.
Hill, Kathleen M., Martin, Berdine R., McCabe, George P., Moe, Sharon M., Peacock, Munro, Wastney, Meryl, Weaver, Connie M.   +6 more
core   +1 more source

Pycnodysostosis With Papilledema and Isolated Low Parathyroid Hormone Levels in an Eight‐Year‐Old Girl: A Genetically Confirmed Case Report

Clinical Case Reports, Volume 14, Issue 4, April 2026.
ABSTRACT Pycnodysostosis is a rare autosomal recessive skeletal dysplasia resulting from pathogenic variants in the CTSK gene, which encodes cathepsin K, a lysosomal cysteine protease expressed in osteoclasts. Deficiency of this enzyme leads to defective bone resorption and generalized osteosclerosis.
Meghana Krishna Kesineni, Naveen Jagadish Kandregula, Sameer Kumar Majety, Yulia Alekseevna Pimenova, Bhargav Kadali, Vineeth Potluri, Prudhvi Lekkala   +6 more
wiley   +1 more source

Genetic Determinants of Phosphate Response in Drosophila [PDF]

, 2012
Phosphate is required for many important cellular processes and having too little phosphate or too much can cause disease and reduce life span in humans.
A Bevington, A Friedman, A Kaffman, A Martin, Adam Friedman, Arunachalam Vinayagam, Bonnie Berger, C Bergwitz, C Bergwitz, C Bergwitz, Charles DeRobertis, Clemens Bergwitz, D Baldridge, D Nair, DA Mason, E Hesse, E Ito, E Laplantine, E Moallem, E Sprecher, F Rossi, Fanis Missirlis, G Huang, GM Chertow, GR Beck Jr, H Steller, HS Tenenhouse, HT Gazda, HW Zhao, IC Lopez-Mejia, IT Flockhart, J Tower, JA Dow, JJ Tong, Joanne Huang, Jonathan Cohen, JR Stubbs, JT Eppig, K Engel, K Mansfield, K Morishita, LA Perkins, Lawrence B. Mensah, Lizabeth A. Perkins, M Dinur, M Julien, M Mizobuchi, M Nechama, M Nechama, M Ohnishi, M Ohnishi, M Yamazaki, Mark J. Wee, MB Eisen, ME Kraus, ME Lenburg, Meghana Kulkarni, Michael Schnall-Levin, MS Razzaque, MY Zhang, Norbert Perrimon, OJ Dunn, OM Gutierrez, P Ferrigno, PR Gardner, R Kilav, R Lyne, RD Page, RK Smith, RS Edgecomb, S Jan De Beur, S Khoshniat, S Yanagawa, SC Hou, SE McGuire, SH Chang, Stephanie E. Mohr, Sumi Sinha, TM Schroeder, VI Perez, VI Perez, VR Chintapalli, W Huang da, Y Hu, Y Oshima, Y Yoshiko, Yanhui Hu   +86 more
core   +4 more sources

Life‐Threatening Acute Tumor Lysis Syndrome With Multiorgan Failure Following First Cycle of Bendamustine–Rituximab in Chronic Lymphocytic Leukemia: A Case Report and Brief Review

Clinical Case Reports, Volume 14, Issue 4, April 2026.
Graphical timeline of the patient’s clinical course. The timeline illustrates key events in a patient with CLL who developed acute tumor lysis syndrome after the first cycle of bendamustine–rituximab, including TLS onset, multiorgan failure, hemodialysis, and full recovery. ABSTRACT Chronic lymphocytic leukemia is not uniformly low risk for tumor lysis
Malegna Temesgen Garuma, Kebede H. Begna, Tesfaye Belete Amare, Mengisteab Kassahun Desta, Derebe Shashigo Leilago, Humud Mohammed Ahmed   +5 more
wiley   +1 more source

Guidelines for writing definitions in ontologies [PDF]

, 2017
Ontologies are being used increasingly to promote the reusability of scientific information by allowing heterogeneous data to be integrated under a common, normalized representation. Definitions play a central role in the use of ontologies both by humans
Ruttenberg, Alan, Seppälä, Selja, Smith, Barry   +2 more
core   +1 more source

p-Cresyl sulfate [PDF]

, 2017
If chronic kidney disease (CKD) is associated with an impairment of kidney function, several uremic solutes are retained. Some of these exert toxic effects, which are called uremic toxins.
Glorieux, Griet, Gryp, Tessa, Vaneechoutte, Mario, Vanholder, Raymond   +3 more
core   +3 more sources

Acute kidney injury on chronic kidney disease: From congestive heart failure to light chain deposition disease and cast nephropathy in multiple myeloma [PDF]

, 2019
Acute on chronic renal failure is a common but notably broad diagnosis. We present a 64-year-old man with a history of diastolic heart failure and chronic kidney disease, admitted for an elevated creatinine.
Cheng, Steven, Lacasse, Alexandre, Nwankwo, Christian, Shaikh, Sana   +3 more
core   +1 more source